These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10853862)

  • 1. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX.
    Andersson C; Roomans GM
    Eur Respir J; 2000 May; 15(5):937-41. PubMed ID: 10853862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of the ion transport defect in cystic fibrosis.
    Roomans GM
    Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for direct activation of the cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine.
    Kunzelmann K; Briel M; Schreiber R; Ricken S; Nitschke R; Greger R
    Cell Physiol Biochem; 1998; 8(4):185-93. PubMed ID: 9694345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CFTR by genistein in human airway epithelial cell lines.
    Andersson C; Servetnyk Z; Roomans GM
    Biochem Biophys Res Commun; 2003 Aug; 308(3):518-22. PubMed ID: 12914781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers.
    Bebok Z; Collawn JF; Wakefield J; Parker W; Li Y; Varga K; Sorscher EJ; Clancy JP
    J Physiol; 2005 Dec; 569(Pt 2):601-15. PubMed ID: 16210354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
    Rubenstein RC; Egan ME; Zeitlin PL
    J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
    Guay-Broder C; Jacobson KA; Barnoy S; Cabantchik ZI; Guggino WB; Zeitlin PL; Turner RJ; Vergara L; Eidelman O; Pollard HB
    Biochemistry; 1995 Jul; 34(28):9079-87. PubMed ID: 7542476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.
    Rubenstein RC; Zeitlin PL
    Am J Respir Crit Care Med; 1998 Feb; 157(2):484-90. PubMed ID: 9476862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein.
    Illek B; Zhang L; Lewis NC; Moss RB; Dong JY; Fischer H
    Am J Physiol; 1999 Oct; 277(4):C833-9. PubMed ID: 10516113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist.
    Namkung W; Park J; Seo Y; Verkman AS
    Mol Pharmacol; 2013 Sep; 84(3):384-92. PubMed ID: 23788656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07.
    Zegarra-Moran O; Romio L; Folli C; Caci E; Becq F; Vierfond JM; Mettey Y; Cabrini G; Fanen P; Galietta LJ
    Br J Pharmacol; 2002 Oct; 137(4):504-12. PubMed ID: 12359632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.
    Rubenstein RC; Zeitlin PL
    Am J Physiol Cell Physiol; 2000 Feb; 278(2):C259-67. PubMed ID: 10666020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers.
    Rowe SM; Pyle LC; Jurkevante A; Varga K; Collawn J; Sloane PA; Woodworth B; Mazur M; Fulton J; Fan L; Li Y; Fortenberry J; Sorscher EJ; Clancy JP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):268-78. PubMed ID: 20226262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
    Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
    J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms.
    He Z; Raman S; Guo Y; Reenstra WW
    Am J Physiol; 1998 Oct; 275(4):C958-66. PubMed ID: 9755049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
    Cohen BE; Lee G; Jacobson KA; Kim YC; Huang Z; Sorscher EJ; Pollard HB
    Biochemistry; 1997 May; 36(21):6455-61. PubMed ID: 9174362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.
    Srivastava M; Eidelman O; Pollard HB
    Mol Med; 1999 Nov; 5(11):753-67. PubMed ID: 10656877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.